Last edition
News about Global Pharma
Refeyn Installs 500th Mass Photometry System, Marking Major Milestone in Bioanalytics
Refeyn, the company behind pioneering mass photometry technology, has announced the installation of the 500th system based on its novel single-particle bioanalytical technology – notably, within just seven years of its spin out from Oxford University in 2018.
Global Pharma | 09/05/2025 | By Manvi | 251
India Pharma Market Grows 7.8 Percent in April: Report
The India Ratings and Research report shows that therapies such as cardiac, gastrointestinal, anti-diabetic, and dermatology received higher volume growth in April.
Global Pharma | 09/05/2025 | By Manvi | 284
Senores Pharmaceuticals Acquires ANDA for Tramadol Tablets from APDM Pharmaceuticals
Senores Pharmaceuticals has acquired the USFDA-approved ANDA for Tramadol Tablets from APDM Pharmaceuticals, using IPO proceeds to strengthen its pain management portfolio in the US market.
Global Pharma | 09/05/2025 | By Manvi | 649
Remlife Global, a Singapore-based subsidiary of Remedium Lifecare, has partnered with JiyaYu Lifesciences to replace animal-origin inputs in the manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates with proprietary fermentation and biocatalyst-based alternatives.
Global Pharma | 09/05/2025 | By Manvi | 240
Suven Pharmaceuticals Rebranded as Cohance Lifesciences
Suven Pharmaceuticals has renamed the company as Cohance Lifesciences with the objective to have a better reach worldwide.
Global Pharma | 08/05/2025 | By Manvi | 1140
Celerion Introduces Enhanced Version of Labnotes Bioanalytical Data Management Software
Celerion has launched an enhanced version of Labnotes, its electronic laboratory notebook software, introducing advanced data management, security, and reporting features to improve operational efficiency and support sponsor success.
Global Pharma | 08/05/2025 | By Manvi | 241
US FDA Appoints Dr. Vinay Prasad to Lead Biologics, Vaccines Division
US FDA selects Dr. Vinay Prasad as the head of the vaccine division of Biologics. The FDA expressed hope that his presence would bring more scrutiny and requirements to developers creating new gene therapies.
Global Pharma | 08/05/2025 | By Manvi | 294
US President Announces High Tariff Rates on Pharmaceutical Imports
America proposes high tariffs on pharmaceutical imports to boost domestic manufacturers.
Global Pharma | 08/05/2025 | By Manvi | 319
Gates Foundation Gives USD 2.5 Million Grant to Evotec for Advancement of TB Treatment
Evotec will utilise the USD 2.5 million grants awarded by the Gates Foundation for the future development of drugs to treat tuberculosis.
Global Pharma | 08/05/2025 | By Manvi | 370
Lupin Launches Eslicarbazepine Acetate Tablets in the United States
Lupin has launched its US FDA-approved generic Eslicarbazepine Acetate Tablets in 200 mg, 400 mg, 600 mg, and 800 mg strengths in the US.
Global Pharma | 07/05/2025 | By Manvi | 230
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy